What is Leerink Partnrs’ Forecast for INSP FY2029 Earnings?

Inspire Medical Systems, Inc. (NYSE:INSP) – Investment analysts at Leerink Partnrs dropped their FY2029 earnings per share (EPS) estimates for shares of Inspire Medical Systems in a report released on Tuesday, August 5th. Leerink Partnrs analyst M. Kratky now anticipates that the company will post earnings per share of $6.27 for the year, down from their previous estimate of $6.69. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $2.16 per share.

INSP has been the topic of a number of other reports. Morgan Stanley decreased their price target on shares of Inspire Medical Systems from $200.00 to $182.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 15th. Stifel Nicolaus set a $140.00 price target on shares of Inspire Medical Systems and gave the company a “hold” rating in a research note on Tuesday. Wells Fargo & Company decreased their price target on shares of Inspire Medical Systems from $174.00 to $101.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Piper Sandler decreased their price target on shares of Inspire Medical Systems from $233.00 to $150.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, Royal Bank Of Canada decreased their price target on shares of Inspire Medical Systems from $215.00 to $180.00 and set an “outperform” rating on the stock in a research note on Tuesday. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $173.31.

Inspire Medical Systems Stock Down 10.7%

INSP stock opened at $78.54 on Wednesday. The company’s 50-day simple moving average is $130.39 and its 200-day simple moving average is $153.83. Inspire Medical Systems has a 52-week low of $73.92 and a 52-week high of $225.00. The firm has a market cap of $2.32 billion, a P/E ratio of 45.40, a PEG ratio of 6.76 and a beta of 1.22.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, August 4th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.23. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The business had revenue of $217.09 million for the quarter, compared to analyst estimates of $214.50 million. During the same period in the prior year, the company posted $0.32 EPS. The company’s revenue for the quarter was up 10.8% on a year-over-year basis.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. True Wealth Design LLC lifted its stake in Inspire Medical Systems by 39.0% in the 4th quarter. True Wealth Design LLC now owns 196 shares of the company’s stock worth $36,000 after purchasing an additional 55 shares in the last quarter. Captrust Financial Advisors increased its holdings in shares of Inspire Medical Systems by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 3,034 shares of the company’s stock worth $562,000 after buying an additional 59 shares during the last quarter. MML Investors Services LLC increased its holdings in shares of Inspire Medical Systems by 0.9% during the 4th quarter. MML Investors Services LLC now owns 7,941 shares of the company’s stock worth $1,472,000 after buying an additional 67 shares during the last quarter. Mariner LLC increased its holdings in shares of Inspire Medical Systems by 1.6% during the 4th quarter. Mariner LLC now owns 4,837 shares of the company’s stock worth $897,000 after buying an additional 77 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in shares of Inspire Medical Systems by 14.6% during the 2nd quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock worth $78,000 after buying an additional 77 shares during the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.